Skip to content

Trevi Therapeutics, Inc. TRVI Income Taxes Paid, Net

Other financials

Income statement

See full
Operating income-$14.9M-30.0%
Net income-$13.2M-27.6%
EPS (diluted)-$0.090.0%

Balance sheet

See full
Cash & equivalents$19.4M+0.2%
Total debt$682.0K-28.7%
Total equity$172.1M+73.1%
Total assets$179.6M+67.8%

Cash flow

See full
Operating cash flow-$16.7M-23.8%
CapEx$102.0K
Free cash flow-$16.8M

Valuation

See full
Market cap$2.49B+152%

Returns & leverage

See full
Return on equity-33.6%-9.4pp
Debt / equity0.0×
Current ratio24.8×+9.4×

Where this comes from

Reported directly by Trevi Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxesPaidNet.

The official record: Trevi Therapeutics, Inc.’s 10-K, filed March 17, 2026, on SEC EDGAR. View the filing →

Questions, answered.

What is Trevi Therapeutics, Inc.'s income taxes paid, net?
Trevi Therapeutics, Inc. (TRVI) reported income taxes paid, net of -$8.25K in Q4 2025.
How has Trevi Therapeutics, Inc.'s income taxes paid, net changed year-over-year?
Trevi Therapeutics, Inc.'s income taxes paid, net decreased by 3.1% year-over-year, from -$8K to -$8.25K.